Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas

Molecular Neurobiology

Volumn 47, Issue 1, 2013, Pages 325-336

  Liu, Zhongyu ^a,b   Xie, Mengyu ^c   Yao, Zhiqiang ^a   Niu, Yulong ^d   Bu, Youquan ^c   Gao, Chunfang ^a  

^a The 150th Central Hospital of People's Liberation Army   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Astrocytoma; Differentially expressed genes; Gene expression; Immunohistochemistry; Meta analysis; Microarray; QT PCR

Indexed keywords

CCNB2 PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; OLIGONUCLEOTIDE; PCNA PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ASTROCYTOMA; BRAIN TISSUE; CELL CYCLE; CLINICAL ARTICLE; FEMALE; GEL ELECTROPHORESIS; GENE EXPRESSION; HUMAN; HUMAN GENOME; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RNA EXTRACTION;

EID: 84872496118     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8367-5     Document Type: Review

References (61)

1. Buckner JC, Brown PD, O'Neill BP et al (2007) Central nervous system tumors. Mayo Clin Proc 82(10):1271-1286
2. Golub TR, Slonim DK, Tamayo P et al (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537
3. Alizadeh A, Eisen M, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
4. Liu ZY, Niu YL, Li C et al (2011) Integrating multiple microarray datasets on oral squamous cell carcinoma to reveal dysregulated networks. Head Neck. doi: 10.1002/hed.22013
5. Collins R, Peto R, Gray R et al (1997) Non-random reflections on health services research. BMJ, London, pp 197-230
6. Rickman DS, Bobek MP, Misek DE et al (2001) Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61:6885-6891
7. Rorive S, Maris C, Debeir O et al (2006) Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. J Neuropathol Exp Neurol 65(8):794-807
8. Sun L, Hui A, Su Q et al (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9:287-300
9. Gravendeel LA, Kouwenhoven MC, Gevaert O et al (2009) Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 69(23):9065-9072
10. Bredel M, Bredel C, Juric D et al (2005) Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65:8679-8689
11. Wu Z, Irizarry RA (2005) Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 12(6):882-893
12. Jaksik R, Polańska J, Herok R et al (2009) Calculation of reliable transcript levels of annotated genes on the basis of multiple probe-sets in Affymetrix microarrays. Acta Biochim Polonila 56(2):271-277
13. Dixon WJ (1953) Processing data for outliers. Biometrics 9(1):74-89
14. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. PNAS 98(9):5116-5121
15. Hong F, Breitling R, McEntee CW et al (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22(22):2825-2827
16. Whitehead A, Whitehead J (1991) A general parametric approach to the meta- analysis of randomised clinical trials. Stat Med 10(11):1665-1677
17. Sutton AJ, Abrams KR, Jones DR et al (2000) Methods for meta-analysis in medical research. Wiley, Chichester
18. Berlin JA, Laird NM, Sacks HS et al (1989) A comparison of statistical methods for combining event rates from clinical trials. Stat Med 8(2):141-151
19. Storey J, Tibshirani R (2003) Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 224:149-157
20. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 4(1):44-57
21. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:741-748
22. Chen H, Huang Q, Dong J et al (2008) Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo. BMC Cancer 8:29. doi: 10.1186/1471-2407-8-29
23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25(4):402-408
24. Stewart ZA, Westfall MD, Pietenpol JA (2003) Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci 24(3):139-145
25. Leonardi E, Girlando S, Serio G et al (1992) PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 45(5):416-419
26. Smetana K, Gyorkey F, Chan PK et al (1983) Proliferating cell nuclear antigen (PCNA) and human malignant nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46(3):133-141
27. Celis JE, Bravo R, Larsen PM et al (1984) Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 8:143-157
28. Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti-PCNA-cylcin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134(3):733-739
29. Galand P, Degraef C (1989) Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tiss Kinet 22(5):383-392
30. Clement V, Sanchez P, de Tribolet N et al (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17(2):165-172
31. Kong DS, Kim MH, Park WY et al (2008) The progression of gliomas is associated with cancer stem cell phenotype. Oncol Rep 19(3):639-643
32. Revesz T, Alsanjari N, Darling JL, et al. (1993) Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas. 19(2):152-158
33. Maiti AK, Ghosh K, Chatterjee U et al (2008) Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas. Neurol India 56(4):456-462
34. Malhan P, Husain N, Bhalla S et al (2010) Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma. Indian J Pathol Microbiol 53(1):20-23
35. Ehrmann J Jr, Kolár Z, VojtÄsek B et al (1997) Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival. Neoplasma 44(5):299-304
36. Kayaselçuk F, Zorludemir S, Gümürdühü D et al (2002) PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neurooncol 57(2):115-121
37. Morgan DL (2007) The cell cycle: principles of control. New Science Press, London, pp 30-31, ISBN 0-19-920610-4
38. Lee MG, Nurse P (1987) Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc. Nature 327(6117):31-35
39. Enserink JM, Kolodner RD (2010) An overview of Cdk1-controlled targets and processes. Cell Div 5(11):1-41
40. Chen H, Huang Q, Dong J, et al (2008) Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo. BMC Cancer 8(29)
41. Otero JJ, Tihan T (2011) Morphological analysis of CDC2 and glycogen synthase kinase 3β phosphorylation as markers of G2 → M transition in glioma. Patholog Res Int 2011:216086
42. Kim JH et al (1999) Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer 85:546-553
43. Marone M et al (1998) Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer 75:34-39
44. Yamamoto H et al (1995) Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 71:1231-1236
45. Yamamoto H et al (1998) Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells. Int J Oncol 13:233-239
46. Geng Y et al (2003) Cyclin E ablation in the mouse. Cell 114:431-443
47. Bortner DM, Rosenberg MP (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17:453-459
48. Ma Y et al (2007) Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acid Sci USA 104:4089-4094
49. Malumbres M, Pevarello P, Barbacid M et al (2008) CDK inhibitors in cancer therapy: what is next? Trends Pharmacol Sci 29:16-21
50. Dirks PB, Hubbard SL, Murakami M et al (1997) Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J Neuropathol Exp Neurol 56(3):291-300
51. Desai SR, Pillai PP, Patel RS et al (2012) Regulation of CDK7 activity through a phosphatidylinositol(3)-kinase/PKC1 mediated signaling cascade in glioblastoma. Carcinogenesis 33(1):10-19
52. Zhao ZY, Liu Y, He H et al (2011) Candidate genes influencing sensitivity and resistance of human glioblastoma to semustine. Brain Res Bull 86(3-4):189-194
53. Phosphosite Organization (2012) CCNB2 (human). Available at: http://www.phosphosite.org/proteinaction.do?id=21425&showAllSites=true. Accessed July 20, 2012
54. Hodgson JG, Yeh RF, Ray A et al (2009) Comparative analyses of gene copy number and mRNA expression in glioblastoma tumors and xenografts. Neuro Oncol 11(5):477-487
55. Gygi SP, Rochon Y, Franza BR et al (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730
56. Futcher B, Latter GI, Monardo P et al (1999) A sampling of the yeast proteome. Mol Cell Biol 19:7357-7368
57. Greenbaum D, Colangelo C, Williams K et al (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4:117
58. Anderson L, Seilhamer J (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537
59. Chen G, Gharib TG, Huang CC et al (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304-313
60. Lichtinghagen R, Musholt PB, Lein M et al (2002) Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 42:398-406
61. Guo Y, Xiao P, Lei S et al (2008) How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (S) 40(5):426-436